Submission of Regulatory Application to MCA

4 March 2003

GW announces that the regulatory dossier for the Company’s first cannabis-based prescription medicine has been submitted to the UK Medicines Control Agency as planned.

- Ends -

GW Pharmaceuticals plc		020 7067 0700
Dr Geoffrey Guy, Chairman
Justin Gover, Managing Director


Weber Shandwick Square Mile		020 7067 0700
Kevin Smith/Graham Herring